These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36462500)

  • 1. Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma.
    Jiayu F; Jiang Y; Zhou X; Zhou M; Pan J; Ke Y; Zhen J; Huang D; Jiang W
    Aging (Albany NY); 2022 Dec; 14(23):9550-9578. PubMed ID: 36462500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma.
    Zhen J; Pan J; Zhou X; Yu Z; Jiang Y; Gong Y; Ding Y; Liu Y; Guo L
    Aging (Albany NY); 2023 Apr; 15(8):2937-2969. PubMed ID: 37074800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZNF320 is a hypomethylated prognostic biomarker involved in immune infiltration of hepatocellular carcinoma and associated with cell cycle.
    Zhen J; Ke Y; Pan J; Zhou M; Zeng H; Song G; Yu Z; Fu B; Liu Y; Huang D; Wu H
    Aging (Albany NY); 2022 Oct; 14(20):8411-8436. PubMed ID: 36287187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
    Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
    Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis and validation of SNX7 as a novel biomarker for the diagnosis, prognosis, and prediction of chemotherapy and immunotherapy response in hepatocellular carcinoma.
    Chen J; Gao G; Zhang Y; Dai P; Huang Y
    BMC Cancer; 2023 Sep; 23(1):899. PubMed ID: 37743471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
    Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
    Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
    Xu H; Xiong C; Chen Y; Zhang C; Bai D
    Bioengineered; 2021 Dec; 12(1):2664-2675. PubMed ID: 34115569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma.
    Fu B; Zhou M; Song G; Zeng H; Gong Y; Jiang Y; Ke Y; Huang D; Peng H; Li Q
    Aging (Albany NY); 2023 Apr; 15(7):2734-2771. PubMed ID: 37059591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of KRBA1 as a Potential Prognostic Biomarker Associated with Immune Infiltration and m6A Modification in Hepatocellular Carcinoma.
    Liu Y; Fu B; Yu Z; Song G; Zeng H; Gong Y; Ding Y; Huang D
    J Hepatocell Carcinoma; 2022; 9():497-516. PubMed ID: 35669909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Biological Function of POLA2 in Hepatocellular Carcinoma.
    Yang Z; Shen X; Wang Z; Li R; Hou W; Liu Z; Gao Y; Zhu C; Qin X
    Comb Chem High Throughput Screen; 2024; 27(12):1758-1775. PubMed ID: 37861044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
    Tian F; Cai D
    Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma.
    Qu LH; Fang Q; Yin T; Yi HM; Mei GB; Hong ZZ; Qiu XB; Zhou R; Dong HF
    Cancer Immunol Immunother; 2022 Oct; 71(10):2449-2467. PubMed ID: 35254477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma.
    Xiao Y; Li J; Wu J
    BMC Med Genomics; 2023 Jul; 16(1):177. PubMed ID: 37525171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Prognostic Value, Immune Implication and Biological Function of
    Huang Y; Huang S; Ma L; Wang Y; Wang X; Xiao L; Qin W; Li L; Yuan X
    Front Immunol; 2021; 12():723293. PubMed ID: 34899687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.
    Cai J; Zhou M; Xu J
    World J Surg Oncol; 2021 Aug; 19(1):241. PubMed ID: 34389000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comprehensive Prognostic Analysis of POLD1 in Hepatocellular Carcinoma.
    Tang H; You T; Sun Z; Bai C
    BMC Cancer; 2022 Feb; 22(1):197. PubMed ID: 35189839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LOXL2 serves as a prognostic biomarker for hepatocellular carcinoma by mediating immune infiltration and vasculogenic mimicry.
    Zhao N; Chen C; Guo Y; Liu T; Che N; Zhang D; Liang X; Zhang Y; Zhao X
    Dig Liver Dis; 2023 May; 55(5):661-672. PubMed ID: 36192339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of Prognostic Value and Immune Infiltration of Src Family Kinases in Hepatocellular Carcinoma.
    Yao D; Deng Y; Zhang S; Liang L; Zhang L; Weng S; Chen S
    Front Biosci (Landmark Ed); 2023 May; 28(5):90. PubMed ID: 37258470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.